Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Medidata Solutions Inc (MDSO)?

Page 1 of 2

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 5.2% over the 12-month period ending October 30, while more than 51% of the constituents of the index underperformed the benchmark. Hence, a random stock picking process will most likely lead to disappointment. At the same time, the 30 most favored S&P 500 stocks by the hedge funds monitored by Insider Monkey (as of September 2014) generated a return of 9.5% over the same time span, with 63% of these stocks outperforming the benchmark. Of course, hedge funds do make wrong bets on some occasions and these get disproportionately publicized in financial media, but piggybacking their moves can beat the broader market on average. That’s why we are going to go over recent hedge fund activity in Medidata Solutions Inc (NASDAQ:MDSO).

Hedge fund interest in Medidata Solutions Inc (NASDAQ:MDSO) shares was flat at the end of last quarter. This is usually a negative indicator. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as PriceSmart, Inc. (NASDAQ:PSMT), The Timken Company (NYSE:TKR), and Domtar Corp (USA) (NYSE:UFS) to gather more data points.

Follow Medidata Solutions Inc. (NASDAQ:MDSO)
Trade (NASDAQ:MDSO) Now!

At the moment there are a lot of formulas market participants can use to appraise publicly traded companies. Some of the most underrated formulas are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the top picks of the best hedge fund managers can beat the S&P 500 by a solid margin (see the details here).

With all of this in mind, we’re going to take a gander at the new action regarding Medidata Solutions Inc (NASDAQ:MDSO).

How are hedge funds trading Medidata Solutions Inc (NASDAQ:MDSO)?

At Q3’s end, a total of 17 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 0% from the second quarter. With hedgies’ sentiment swirling, there exists a select group of noteworthy hedge fund managers who were upping their holdings significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Polar Capital, managed by Brian Ashford-Russell and Tim Woolley, holds the biggest position in Medidata Solutions Inc (NASDAQ:MDSO). Polar Capital has a $17.7 million position in the stock, comprising 0.4% of its 13F portfolio. Sitting at the No. 2 spot is ShearLink Capital, managed by Vivek Mehta and Aaron Husock, which holds a $16.3 million position; 7.2% of its 13F portfolio is allocated to the stock. Other members of the smart money that are bullish contain Nick Niell’s Arrowgrass Capital Partners, Drew Cupps’s Cupps Capital Management and Chuck Royce’s Royce & Associates.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!